Old Mutual Customised Solutions’s Nektar Therapeutics NKTR Stock Holding History

Old Mutual Customised Solutions’s Portfolio NKTR Stock Details NKTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$78K	Buy	+107	New	+$123K	0.01%	712

Other funds holding NKTR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Old Mutual Customised Solutions's NKTR Position: Q2 2018 in Review

Old Mutual Customised Solutions opened a new position in Nektar Therapeutics (NKTR) in Q2 2018: 107 shares worth $78K. The stake represents 0.01% of the portfolio and ranks #712 among its holdings.

378 funds tracked by Wall St. Rank hold NKTR as of Q2 2018.

Old Mutual Customised Solutions held 107 shares of Nektar Therapeutics worth $78K as of Q2 2018.
Nektar Therapeutics was a new Old Mutual Customised Solutions position in Q2 2018.
Nektar Therapeutics made up 0.01% of Old Mutual Customised Solutions's portfolio in Q2 2018, its #712 holding.
378 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2018.

Based on Old Mutual Customised Solutions's 13F filing for Q2 2018, filed 14 Aug 2018.